Thyroid Management in Pregnancy

Introduction to Thyroid Management

Thyroid management in pregnancy is crucial to prevent complications, with the American Academy of Family Physicians providing guidelines for treatment 1, 2

The American Academy of Family Physicians recommends levothyroxine therapy to normalize maternal TSH levels, starting with an appropriate dosage and adjusting every 4 weeks until TSH level is stable, to prevent complications such as preeclampsia, low birth weight, and potential neuropsychological deficits in offspring 1

Overtreatment with methimazole can cause iatrogenic hypothyroidism and potential fetal/neonatal hypothyroidism, while the American Academy of Family Physicians recommends methimazole as the preferred medication for treating hyperthyroidism during the second and third trimesters due to its lower risk of hepatotoxicity compared to propylthiouracil (PTU) 1, 2
Propylthiouracil (PTU) is preferred in the first trimester due to potential teratogenicity associated with methimazole, with the evidence strongly supporting the use of PTU in the first trimester followed by methimazole for the remainder of pregnancy as the safest approach, with a strength of evidence considered high 3, 2
The initial dose of methimazole is recommended to be 0.4 mg/kg body weight daily, divided into 3 doses given at 8-hour intervals, with a maintenance dose of approximately half of the initial dose, and thyroid function should be monitored every 2-4 weeks initially, then every 3-6 months once stable, with the goal of maintaining free T4 or Free T4 Index in the high-normal range using the lowest possible dose, as per standard clinical practice and recommended by the American Family Physician and the Endocrine Society 2, 1, 3

Monitor thyroid function every 2-4 weeks initially until stable, and measure free T4 or FTI every two to four weeks to adjust dosing appropriately, as recommended by the American Academy of Family Physicians 1
Potential side effects of methimazole include agranulocytosis, hepatitis, vasculitis, and thrombocytopenia, and if agranulocytosis symptoms develop, a complete blood count should be obtained and methimazole discontinued, as suggested by the American Family Physician 1
Beta blockers (e.g., propranolol) can be used temporarily to control symptoms until methimazole reduces thyroid hormone levels, according to the American Academy of Family Physicians 1
Methimazole should be taken with food to minimize gastrointestinal side effects, and can be taken at the same time each day to maintain consistent blood levels, as suggested by the American Family Physician 2

Suppression of fetal and neonatal thyroid function with thioamide therapy is usually transient, as stated by the American Academy of Family Physicians 1
Women treated with methimazole can safely breastfeed, as recommended by the American Academy of Family Physicians, and the American Academy of Pediatrics recommends monitoring infant thyroid function at frequent (weekly or biweekly) intervals when the mother is breastfeeding while on methimazole 1, 4
The newborn's physician should be informed of maternal hyperthyroidism treatment, as advised by the American Academy of Family Physicians 1

Radioactive iodine (I-131) treatment is absolutely contraindicated during pregnancy, as stated by the American Academy of Family Physicians 1
Treatment duration for patients with Graves' disease is typically 12-18 months, although this can vary based on individual patient factors, as reported by the American Family Physician 1
Thyroid function often improves as pregnancy progresses, potentially allowing for dose reduction later in pregnancy, according to the American Academy of Family Physicians 2

Propylthiouracil (PTU) is associated with a lower risk of congenital malformations in the first trimester, but a higher risk of severe liver injury compared to carbimazole/methimazole, and the odds of liver function injury and elevated transaminases are higher with PTU, as reported by the American Family Physician 1
PTU blocks peripheral conversion of T4 to T3, while carbimazole/methimazole has a different mechanism of action, and PTU is recommended for use in the first trimester of pregnancy due to its side effect profile, as suggested by the Endocrine Society and the American Family Physician 5, 1, 3
Carbimazole is rapidly metabolized to methimazole, its active form, after absorption, and has a longer half-life than PTU, allowing for once-daily dosing, while PTU requires multiple daily doses 1